These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34773572)

  • 1. One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study.
    Guo J; Qiu X; Tang W; Xu G; Moyers MF; Ren W; Xing Y; Gao J; Sun J; Lu J; Kong L; Liu W
    Ophthalmol Ther; 2022 Feb; 11(1):187-199. PubMed ID: 34773572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data.
    Qi HJ; Jin EZ; Zhao MW
    Int J Ophthalmol; 2019; 12(1):51-57. PubMed ID: 30662840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV.
    Li F; Ma A; Zhao B
    Biomed Res Int; 2020; 2020():2428348. PubMed ID: 32382537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48-week randomized phase 4 study: STAR study.
    Li X; Qu J; Su G; Yu S; Zhang Y; Sadda SV;
    Acta Ophthalmol; 2023 May; 101(3):e327-e337. PubMed ID: 36259089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year results of intravitreal conbercept in treatment-naïve subjects with polypoidal choroidal vasculopathy.
    Ye LH; Cai Y; Shi X; Wong IYH; Qu JF; Zhao MW; Ying X; Li XX
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1455-1462. PubMed ID: 33146832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept.
    Xue Y; Qinhua C
    Front Med (Lausanne); 2022; 9():835255. PubMed ID: 35252267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy.
    Sun Z; Gong Y; Yang Y; Huang Y; Yu S; Pei J; Lin B; Zhou R; Li Y; Li Y; Zhang J; Liu X
    Front Med (Lausanne); 2021; 8():791935. PubMed ID: 35223882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
    Saito M; Iida T; Kano M; Itagaki K
    Eye (Lond); 2013 Aug; 27(8):931-9. PubMed ID: 23743532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumab.
    Saito M; Kano M; Itagaki K; Oguchi Y; Sekiryu T
    Retina; 2014 Nov; 34(11):2192-201. PubMed ID: 25077530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHORT-TERM EFFICACY OF CONBERCEPT AND RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Huang Z; Ding Q; Yan M; Lian H; Chen Z; Chen X; Song Y
    Retina; 2019 May; 39(5):889-895. PubMed ID: 29360683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.
    Cheng Y; Shi X; Qu JF; Zhao MW; Li XX
    Chin Med J (Engl); 2016 Nov; 129(21):2610-2616. PubMed ID: 27779169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.
    Koh A; Lai TYY; Takahashi K; Wong TY; Chen LJ; Ruamviboonsuk P; Tan CS; Feller C; Margaron P; Lim TH; Lee WK;
    JAMA Ophthalmol; 2017 Nov; 135(11):1206-1213. PubMed ID: 28983556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
    Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
    Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypoidal choroidal vasculopathy exudation and hemorrhage: results of monthly ranibizumab therapy at one year.
    Kokame GT; Yeung L; Teramoto K; Lai JC; Wee R
    Ophthalmologica; 2014; 231(2):94-102. PubMed ID: 24135557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
    Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
    Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.